《新股消息》富衛集團以同股同權形式申請在港上市
李澤楷旗下富衛集團(FWD)昨晚(2月28日)向聯交所提交主板上市申請,聯席保薦人爲摩根士丹利、高盛、招銀國際及摩根大通。近日有市場消息指,富衛集團最快於今年上半年上市,籌集約10億美元,集資規模較去年傳出的20億至30億美元縮減。
富衛集團現時業務覆蓋港澳、泰國、柬埔寨、日本、菲律賓、印尼、新加坡、越南和馬來西亞等10個市場,2021年新業務價值總額爲6.86億美元,全年總收益達到116.97億美元,按年增長23.3%,純利錄1.88億美元,對比2020年爲虧損2.68億美元。
集團預期,所得資金將用於加強股本、償付能力、中央流動資金,以及建立超出適用法定要求的資本緩衝;以及用作對印尼人民銀行人壽保險的額外承諾出資。
富衛集團以同股同權形式提交是次IPO申請,去年初有傳富衛考慮在新加坡上市,或與美國上市的SPAC合併,從而維持雙重股份架構。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.